Literature DB >> 24558240

Draft Genome Sequence of mc251, a Highly Hydrogen Peroxide-Resistant Mycobacterium smegmatis Mutant Strain.

Xiaojing Li1, Fei Liu, Yongfei Hu, Kaixia Mi.   

Abstract

Here, we report the draft genome sequence of the Mycobacterium tuberculosis-like Mycobacterium smegmatis mutant strain, mc(2)51, compared to that of wild-type strain M. smegmatis mc(2)155. The draft genome sequence comprises 6,823,739 bp, revealing 6,569 coding DNA sequences (CDSs) and 50 RNA genes (4 rRNA genes and 46 tRNA genes).

Entities:  

Year:  2014        PMID: 24558240      PMCID: PMC3931361          DOI: 10.1128/genomeA.00092-14

Source DB:  PubMed          Journal:  Genome Announc


GENOME ANNOUNCEMENT

It is known that a successfully established infection of Mycobacterium tuberculosis is partially due to its ability to survive and persist in macrophages (1). To defend against infection, the production of reactive oxygen species (ROS) by the host is one of important classical innate mechanisms. Accordingly, to overcome ROS stresses, mycobacteria have evolved many detoxification strategies to scavenge H2O2, the major contributor of ROS (2). As a model bacterium, Mycobacterium smegmatis is widely used for investigating mycobacterial physiology, drug selection, and vaccine development (3–8). Historically, continuous selection was an effective method for making mutant strains. For example, Mycobacterium bovis BCG, the only vaccine against tuberculosis, was attenuated by serial passage of M. bovis in vitro over 13 years (9). We used a similar adaptive evolution strategy that mimicked the host environment of H2O2 stress by gradually increasing H2O2 concentrations to select H2O2-resistant M. smegmatis mutants. After 54-day selection, we obtained the M. tuberculosis-like M. smegmatis mutant strain, mc251, with an 80-fold higher MIC of H2O2 and a 100-fold lower MIC (0.1 mg/liter) of isoniazid compared to those of wild-type M. smegmatis mc2155; this is similar to M. tuberculosis with its high resistance to H2O2 and conversely, susceptibility to isoniazid. In addition, the mutant strain mc251 shows slow growth and has a growth advantage in macrophages compared to wild-type mc2155. We therefore sequenced the whole genome of the mutant strain to explore the genomic variations that are potentially involved into its phenotype. The genome of M. smemgatis mc251 was sequenced on an Illumina HiSeq 2000 platform. A total of 4,123,831 paired-end reads with a length of 100 bp, corresponding to 121-fold coverage of the genome, were generated. Raw reads were first filtered using the DynamicTrim and LengthSort Perl scripts provided in the SolexaQA suite (10) and then assembled using SOAPdenovo (http://soap.genomics.org.cn), yielding 96 scaffolds with an average length of 71,080 bp. The draft genome comprises 6,823,739 bp, with 67.4% G+C content and an N50 length of 150,887 bp. The genome was annotated using the Rapid Annotations using Subsystems Technology (RAST) program (11), revealing 6,569 coding DNA sequences (CDSs) and 50 RNA genes (4 rRNA genes and 46 tRNA genes). We then used the Burrows-Wheeler Aligner (BWA)/SAMtools (12) to call single nucleotide polymorphisms (SNPs). Compared with the parental strain mc2155, 22 SNPs were identified in the mutant genome. Nineteen of these mutations are located in the coding regions, and 12 of the 19 SNPs are nonsynonymous mutations. Interestingly, we found nonsynonymous mutations in several genes encoding detoxified enzymes, including dehydrogenase, oxidase, and monooxygenase. We also identified a mutation in the fur gene encoding a ferric uptake regulator, which is located immediately upstream of the catalase-peroxidase KatG. The SNPs of fur were also found in isoniazid (INH)-resistant clinical isolates, which implies that the mutants of Fur might be produced in humans. The information will undoubtedly shed light on the ways in which mycobacteria adjust their own fitness and acquire persistent in macrophages, which might give new insights into designing control strategies against M. tuberculosis.

Nucleotide sequence accession number.

The draft genome sequence has been deposited at DDBJ/EMBL/GenBank under the accession no. JAJD00000000. The version described in this paper is the first version.
  11 in total

1.  First novel anti-tuberculosis drug in 40 years.

Authors:  Randy Osborne
Journal:  Nat Biotechnol       Date:  2013-02       Impact factor: 54.908

2.  Importance of uracil DNA glycosylase in Pseudomonas aeruginosa and Mycobacterium smegmatis, G+C-rich bacteria, in mutation prevention, tolerance to acidified nitrite, and endurance in mouse macrophages.

Authors:  Jeganathan Venkatesh; Pradeep Kumar; Pulukuri Sai Murali Krishna; Ramanathapuram Manjunath; Umesh Varshney
Journal:  J Biol Chem       Date:  2003-04-05       Impact factor: 5.157

3.  Mycobacterial FurA is a negative regulator of catalase-peroxidase gene katG.

Authors:  T C Zahrt; J Song; J Siple; V Deretic
Journal:  Mol Microbiol       Date:  2001-03       Impact factor: 3.501

4.  A recombinant Mycobacterium smegmatis induces potent bactericidal immunity against Mycobacterium tuberculosis.

Authors:  Kari A Sweeney; Dee N Dao; Michael F Goldberg; Tsungda Hsu; Manjunatha M Venkataswamy; Marcela Henao-Tamayo; Diane Ordway; Rani S Sellers; Paras Jain; Bing Chen; Mei Chen; John Kim; Regy Lukose; John Chan; Ian M Orme; Steven A Porcelli; William R Jacobs
Journal:  Nat Med       Date:  2011-09-04       Impact factor: 53.440

5.  Infection of macrophages with Mycobacterium tuberculosis induces global modifications to phagosomal function.

Authors:  Maria Podinovskaia; Wonsik Lee; Shannon Caldwell; David G Russell
Journal:  Cell Microbiol       Date:  2013-01-09       Impact factor: 3.715

Review 6.  Mycobacterium tuberculosis and the macrophage: maintaining a balance.

Authors:  Jean Pieters
Journal:  Cell Host Microbe       Date:  2008-06-12       Impact factor: 21.023

7.  Mycobacterium fluoroquinolone resistance protein B, a novel small GTPase, is involved in the regulation of DNA gyrase and drug resistance.

Authors:  Jun Tao; Jiao Han; Hanyu Wu; Xinling Hu; Jiaoyu Deng; Joy Fleming; Anthony Maxwell; Lijun Bi; Kaixia Mi
Journal:  Nucleic Acids Res       Date:  2012-12-28       Impact factor: 16.971

8.  SolexaQA: At-a-glance quality assessment of Illumina second-generation sequencing data.

Authors:  Murray P Cox; Daniel A Peterson; Patrick J Biggs
Journal:  BMC Bioinformatics       Date:  2010-09-27       Impact factor: 3.169

9.  Fast and accurate short read alignment with Burrows-Wheeler transform.

Authors:  Heng Li; Richard Durbin
Journal:  Bioinformatics       Date:  2009-05-18       Impact factor: 6.937

10.  The RAST Server: rapid annotations using subsystems technology.

Authors:  Ramy K Aziz; Daniela Bartels; Aaron A Best; Matthew DeJongh; Terrence Disz; Robert A Edwards; Kevin Formsma; Svetlana Gerdes; Elizabeth M Glass; Michael Kubal; Folker Meyer; Gary J Olsen; Robert Olson; Andrei L Osterman; Ross A Overbeek; Leslie K McNeil; Daniel Paarmann; Tobias Paczian; Bruce Parrello; Gordon D Pusch; Claudia Reich; Rick Stevens; Olga Vassieva; Veronika Vonstein; Andreas Wilke; Olga Zagnitko
Journal:  BMC Genomics       Date:  2008-02-08       Impact factor: 3.969

View more
  3 in total

1.  Experimental Evolution Reveals Redox State Modulates Mycobacterial Pathogenicity.

Authors:  Zheng Jiang; Zengfang Zhuang; Kaixia Mi
Journal:  Front Genet       Date:  2022-03-16       Impact factor: 4.599

2.  Structure of Mycobacterium tuberculosis cytochrome bcc in complex with Q203 and TB47, two anti-TB drug candidates.

Authors:  Shan Zhou; Weiwei Wang; Xiaoting Zhou; Yuying Zhang; Yuezheng Lai; Yanting Tang; Jinxu Xu; Dongmei Li; Jianping Lin; Xiaolin Yang; Ting Ran; Hongming Chen; Luke W Guddat; Quan Wang; Yan Gao; Zihe Rao; Hongri Gong
Journal:  Elife       Date:  2021-11-25       Impact factor: 8.140

3.  Cryo-EM structure of trimeric Mycobacterium smegmatis succinate dehydrogenase with a membrane-anchor SdhF.

Authors:  Hongri Gong; Yan Gao; Xiaoting Zhou; Yu Xiao; Weiwei Wang; Yanting Tang; Shan Zhou; Yuying Zhang; Wenxin Ji; Lu Yu; Changlin Tian; Sin Man Lam; Guanghou Shui; Luke W Guddat; Luet-Lok Wong; Quan Wang; Zihe Rao
Journal:  Nat Commun       Date:  2020-08-25       Impact factor: 14.919

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.